CNN-based arrhythmia classifier that fuses the magnitude (scalogram) and phase (phasogram) of the continuous wavelet transform (CWT) of ECG heartbeats, rather than relying on magnitude information alone as most prior 2D-representation approaches do. Several fusion strategies (input-level, intermediate-layer, and output-level fusion) were compared on the public PhysioNet MIT-BIH Arrhythmia database. Despite a simple CNN architecture, the best fusion strategy achieved about 98.5% overall accuracy, 98.5% sensitivity and 95.6% specificity, competitive with more complex state-of-the-art approaches.

Optimized Hierarchical Fused Fuzzy Deep Reinforcement Learning model for predicting non-sinus (higher-risk) cardiac rhythms from PQRST-analyzed 12-lead ECG data. The three-stage approach combines data preprocessing, reinforcement learning, and fuzzy deep learning to classify sinus vs. non-sinus rhythms. Evaluated on a 12-lead ECG dataset of 10,646 patients, OHFFDRL achieved 94% accuracy, an AUC of 0.91, and was interpreted using SHAP, LIME, calibration curves, adversarial vulnerability analysis, and integrated gradients; TAxis (ventricular repolarization movement range) was found to be the most important distinguishing feature.

Ensemble classifier combining hand-engineered expert features with a deep convolutional neural network for classifying cardiac rhythm from a single-lead ECG recording into normal sinus rhythm, atrial fibrillation, another rhythm, or too noisy to classify. A large set of expert features (from time-, frequency-, and template-based analysis) is fed into a gradient-boosted tree classifier (AdaBoost), and its output is combined with a separate deep CNN operating directly on the raw waveform; combining both feature families measurably outperformed either alone. ENCASE won 1st place in the PhysioNet/Computing in Cardiology Challenge 2017 (single-lead AF classification) with an overall F1 score of 0.83 on the official hidden test set, and remains a widely cited example of combining classical signal-processing features with deep representations for ECG classification.

Multi-outcome AI-ECG risk-estimation platform that turns a single 12-lead ECG into a patient-specific survival curve, using a residual convolutional neural network trained with a discrete-time survival loss to predict not just risk but time-to-event. Beyond all-cause and cardiovascular mortality, separately fine-tuned heads predict future ventricular arrhythmia, complete heart block, atrial fibrillation, atherosclerotic cardiovascular disease, heart failure, and (in follow-up work) hypertension -- all from a single resting ECG, including in ECGs a cardiologist would read as normal. Derived on 1.16 million ECGs from 189,539 Beth Israel Deaconess Medical Center patients and externally validated across transnational cohorts in the USA, Brazil (CODE), and the UK (UK Biobank). A variational autoencoder and genome/phenome-wide association analyses were used to show the model's predictions track biologically plausible features (QRS morphology, LV structure/function, and loci linked to cardiac structure, QT interval, and biological aging). NHS trials of AIRE were planned for late 2025. No public code or model weights have been released.

ECG-guided photoplethysmography (PPG) foundation model pretrained on over 100,000 hours of synchronized PPG-ECG recordings from 58,796 subjects across five clinical and wearable sources, using a CLIP-style contrastive alignment framework so the PPG encoder inherits physiologically grounded structure from paired ECG. Achieves state-of-the-art performance on 13 of 15 conventional physiological-analysis tasks across eight datasets, and shows meaningful discriminative capability (AUC >= 0.70) for 307 ICD-10-coded phenotypes across 16 phecode chapters, including many non-cardiovascular conditions.

Supervised EfficientNetV2-based 12-lead ECG model trained on over 1 million ECGs from the Montreal Heart Institute to predict 77 cardiac conditions derived from American Heart Association recommendations, plus fine-tuned digital-biomarker heads for reduced LVEF, 5-year atrial-fibrillation risk, and long-QT-syndrome (LQTS) detection/genotyping. Validated on 881,403 ECGs across 11 geographically diverse cohorts (4 public, 7 private health systems), achieving AUROCs above 0.98 for the 77-condition interpretation task while being 60x smaller and 29x faster at inference than its self-supervised DeepECG-SSL counterpart, with up to 9.7x lower CO2 emissions on equivalent tasks.

Self-supervised EfficientNetV2-based 12-lead ECG foundation model pretrained via contrastive learning and masked-lead modeling on 1.9 million ECGs (Montreal Heart Institute plus CODE-15% and MIMIC-IV), then fine-tuned for the same 77-condition ECG interpretation task and digital-biomarker extraction as DeepECG-SL. Outperforms the supervised counterpart on label-scarce digital-biomarker tasks, with the largest gains on LQTS genotype classification (AUROC 0.931 vs. 0.850, n=127 ECGs) and 5-year atrial-fibrillation risk (AUROC 0.742 vs. 0.734, n=132,050 ECGs), and outperforms ECG-FM and ECGFounder on shared external diagnostic classes.

Explainable Inception-style 1D CNN for multi-label arrhythmia detection from 12-lead ECGs, integrating Grad-CAM visualization to highlight the waveform segments driving each prediction. Trained on MIMIC-IV-ECG and externally validated on PTB-XL across atrial fibrillation, sinus tachycardia, conduction disturbances (RBBB/LBBB/LAFB), long QT, Wolff-Parkinson-White pattern, and paced-rhythm detection, with all metrics exceeding 90% internally and strong generalization on external validation.

Patch-based masked-training framework for robust arrhythmia detection from digitized, multi-layout ECG images (e.g. 3x4, 2x6, 12x1 printed/scanned layouts), designed to handle the asynchronous lead timing and partial signal blackout that digitization introduces. An adaptive variable block-count masking strategy focuses model attention on key patches with cross-lead dependencies. Evaluated on PTB-XL digitized into multiple synthetic layouts and externally validated on 400 real digitized ECG images from Chaoyang Hospital, outperforming classical imputation baselines and the CNN foundation model ECGFounder.

Self-supervised foundation model for photoplethysmography (PPG) that explicitly targets the low-signal-quality problem endemic to real-world wearable and bedside PPG, rather than assuming clean input. A Siamese ResNet (SimSiam-style) encoder is pretrained to produce similar representations for temporally-adjacent high- and low-quality PPG segments presumed to share the same underlying physiological state, with curriculum learning that gradually increases the artifact-level gap between paired segments. Pretrained on over 36 million 30-second PPG pairs drawn from more than 24,100 UCSF ICU patients, then fine-tuned and evaluated on six downstream cardiovascular-monitoring datasets/tasks (heart rate, respiratory rate, blood pressure, and atrial-fibrillation detection), where it exceeds prior state-of-the-art by roughly 75% on respiratory-rate estimation and 5% on AF detection, with performance scaling with backbone depth (ResNet152 best). Code and the pretraining dataset are not public; the pretraining data is available upon request under a UCSF-Emory data use agreement.

ECG foundation model designed to remain accurate when leads are missing or signals are noisy. A 1D ConvNeXt V2 encoder is trained with a dual-mode self-distillation objective (separate lead-missing and noise "teachers") alongside contrastive alignment to detailed diagnostic-criteria text reports retrieved via a lightweight, LLM-free "Cardiac Feature Retrieval" module. Consistently ranks best or second-best across PTB-XL diagnostic tasks and MIT-BIH arrhythmia classification under original, noisy, lead-missing, and combined-corruption conditions. Developed by FPT Software AI Center and the University of Arkansas.

ECG foundation model built on the xLSTM (extended LSTM) architecture: a bidirectional stack of nine alternating scalar- and matrix-memory LSTM blocks that scales linearly with sequence length, unlike the quadratic cost of transformer-based ECG models. Pretrained with SimDINOv2, a coding-rate-regularized self-distillation (DINO) objective adapted from computer vision to ECG time series, on roughly 8 million recordings from CODE, INCART, and Chapman-Shaoxing-Ningbo. Introduced alongside BenchECG, a standardized 8-dataset/10-task benchmark, on which xECG achieves the best average rank of any publicly available ECG foundation model, with particular strength on long-context tasks (30-minute ambulatory arrhythmia classification, multi-hour sleep-apnea segmentation) where transformer-based models are computationally limited.

Multi-task model that jointly assesses signal quality and detects atrial fibrillation from wrist-worn wearable photoplethysmography (PPG), pretrained on roughly one million simulated unlabeled signals before fine-tuning on labeled wearable data. Uses a 1D CNN with separate output heads for signal quality and arrhythmia detection. Developed by Stanford's Ashley Lab.

Dual-encoder single-lead ECG classifier for atrial fibrillation detection that fuses a raw-signal branch with a spectrogram branch via axial attention and a Transformer. Originally developed as a graduate-course project at TU Darmstadt for the 2017 PhysioNet/CinC Challenge, and later extended in a 2023 follow-up study. Released in four sizes up to 130M parameters (S/M/L/XL), alongside a simpler CNN+LSTM variant.

Open ECG foundation model with 90.9M parameters, built on a wav2vec 2.0-style Transformer and pretrained on 1.25-1.5 million ECGs using a hybrid contrastive-and-generative self-supervised objective. Base pretrained weights and MIMIC-IV-ECG-finetuned downstream checkpoints are both released. Developed on the fairseq_signals framework by the University of Toronto / Vector Institute's Wang lab.

Multi-task 12-lead ECG model with output heads for incident atrial-fibrillation risk (as a survival curve), incident mortality risk, prevalent AF classification, sex classification, and age regression. Built on a 1D CNN over the raw waveform, and developed by the Broad Institute's ML4H group as a successor to their ECG-AI model published in Circulation. Trained on ECGs from UK Biobank and Massachusetts General Hospital, neither of which is publicly released.